Insider · CIK 0001691265
Edward R. Conner
officer
Files at THRD (Third Harmonic Bio, Inc.). First filing Oct 30, 2024, latest Nov 12, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $72k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Third Harmonic Bio, Inc. | $32k 2,117 shares | -100% | - | |
| 14Weak | Third Harmonic Bio, Inc. | $40k 2,673 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | THRD Third Harmonic Bio, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +132,000 | $0.00 | $0 | 132,000 | Jan 17, 2025 |
| Jan 15, 2025 | THRD Third Harmonic Bio, Inc. | AGrant or award Restricted Stock Unitderivative | +16,500 | $0.00 | $0 | 16,500 | Jan 17, 2025 |
| Nov 8, 2024 | THRD Third Harmonic Bio, Inc. | MOption exercise Common Stock10b5-1 | +2,117 | $4.20 | $8,891 | 2,117 | Nov 12, 2024 |
| Nov 8, 2024 | THRD Third Harmonic Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -2,117 | $15.00 | $32k | 0 | Nov 12, 2024 |
| Nov 8, 2024 | THRD Third Harmonic Bio, Inc. | MOption exercise Employee Option Grant (right to buy)derivative10b5-1 | -2,117 | $0.00 | $0 | 368,918 | Nov 12, 2024 |
| Oct 28, 2024 | THRD Third Harmonic Bio, Inc. | MOption exercise Common Stock10b5-1 | +2,673 | $4.20 | $11k | 2,673 | Oct 30, 2024 |
| Oct 28, 2024 | THRD Third Harmonic Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -2,673 | $15.00 | $40k | 0 | Oct 30, 2024 |
| Oct 28, 2024 | THRD Third Harmonic Bio, Inc. | MOption exercise Employee Option Grant (right to buy)derivative10b5-1 | -2,673 | $0.00 | $0 | 371,035 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.